- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03328286
Improving Integration of Mentally Burdened Young Adults in the Labour Market (inklusiv)
Young adults who do not successfully transition from compulsory education to upper secondary level are at increased risk of developing mental illness, as compared with their working peers. The causality is unclear: they are either unable to find a job due to a pre-existing mental illness, or their failure in finding a job has contributed to the mental illness.
The Zurich University of Applied Sciences has developed an innovative intervention that includes psychotherapeutic support in a work integration programme. Recognising and treating mental illness early increases the chances of a successful transition to the labour market.
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Zürich, Switzerland, 8037
- Toni Areal
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 16 to 25
- Participation in work integration programme "Lifetimehealth"
Exclusion Criteria:
- Insufficient knowledge of German
- Participant is under guardianship which doesn't allow legal capacity to act
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Weekly group meeting w/psychotherapist
All the participants fulfilling the eligibility criteria are asked to take part in an additional Intervention.
The Intervention is a weekly group Meeting with a psychotherapist to discuss issues or Problems the Group members have
|
Introduce a Psychotherapist in a work Integration program to further support Young adults in Job search and at the same time offering psychotherapeutic counselling.
The participants will have a weekly meeting lasting 1.5 hour and additionally the can have 5 private counselling sessions with the psychotherapist if they wish
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Work Ability
Time Frame: Up to 2 years
|
Increase in work ability of participants, measured with the Work Ability Index. The Work Ability Index (WAI) is an instrument used in occupational health care and research to assess work ability of workers during health examinations and workplace surveys. The purpose of WAI is to help define necessary actions to maintain and promote work ability. The scoring system of the questionnaire categorises work ability, with recommendations for action provided for each category. Appropriate action can then be taken to prevent declining work ability.Each answer has a different score, with users calculating their total points to determine their final score. The minimum is 7, the maximum is 49. The four categories of scores and the objectives of the measures to be taken are as follows:
|
Up to 2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Self-esteem
Time Frame: Up to 2 years
|
Increase in self-esteem of participants, measured with the Rosenberg Self-esteem Scale (SES). The SES is a 10-item scale that measures global self-worth by measuring both positive and negative feelings about the self. Scores are calculated as follows: •For items 1, 2, 4, 6, and 7: Strongly agree = 3 Agree = 2 Disagree = 1 Strongly disagree = 0 •For items 3, 5, 8, 9, and 10 (which are reversed in valence): Strongly agree = 0 Agree = 1 Disagree = 2 Strongly disagree = 3 The scale ranges from 0-30. Scores between 15 and 25 are within normal range; scores below 15 suggest low self-esteem. |
Up to 2 years
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-00936
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Mental Disorder
-
Vincent AgyapongNova Scotia Health Authority; Dalhousie UniversityRecruitingGeneralized Anxiety Disorder | Major Depressive Disorder | Mental Health Wellness 1Canada
-
Otsuka Pharmaceutical Development & Commercialization...CompletedSchizophrenia | Major Depressive Disorder | Mental Disorder | Bipolar I DisorderUnited States
-
Brigham and Women's HospitalRecruitingDepression | Mood Disorders | Depressive Disorder, Major | Psychiatric Disorder | Mental DisorderUnited States
-
Queen's UniversityCompleted
-
Samsung Medical CenterUnknownMajor Depressive Disorder, Anxiety DisorderKorea, Republic of
-
Brigham and Women's HospitalNot yet recruitingDepression | PTSD | Mood Disorders | Anxiety Disorders | OCD | Major Depressive Disorder | Psychiatric Disorder | Mental Disorder
-
York UniversityCentre for Addiction and Mental HealthSuspendedDisorder, Major DepressiveCanada
-
University of OuluCompletedSeasonal Affective Disorder (SAD)Finland
-
H. Lundbeck A/SCompletedMajor Depression DisorderGermany, United States, Estonia, Finland, Poland
-
GlaxoSmithKlineCompleted
Clinical Trials on Weekly group meeting w/psychotherapist
-
University of California, San FranciscoNational Institute of Dental and Craniofacial Research (NIDCR)Not yet recruitingHIV Infections | Oropharyngeal Squamous Cell Carcinoma | Oral Squamous Cell CarcinomaUnited States
-
Dr. Reddy's Laboratories LimitedCompleted
-
University Hospital, Basel, SwitzerlandKrebsforschung Schweiz, Bern, SwitzerlandCompleted
-
Youngstown State UniversityCompleted
-
King Faisal Specialist Hospital & Research CenterCompletedHypopharyngeal Neoplasms | Laryngeal NeoplasmsSaudi Arabia
-
University of PennsylvaniaMichigan State University; Institute of Education SciencesEnrolling by invitation
-
eSupport HealthCompletedMultiple SclerosisUnited States
-
University of Texas at AustinCompletedMultiple SclerosisUnited States
-
Boston Medical CenterCompletedObesity | OverweightUnited States
-
Carilion ClinicNational Institutes of Health (NIH); Virginia Polytechnic Institute and State... and other collaboratorsActive, not recruitingQuality of Life | Obesity | Endometrial Cancer | Sedentary Behavior | SurvivorshipUnited States